Lightstone Ventures' most recent fund, Lightstone Ventures III, successfully closed with $375 million in capital commitments.
Lightstone Ventures III: Fund Details
Lightstone Ventures, a global venture capital firm specializing in healthcare investments, announced the successful closing of its Lightstone Ventures III fund on September 24, 2021. This fund significantly exceeded its targeted raise, demonstrating strong investor confidence by being over-subscribed.
The $375 million fund is dedicated to investing in innovative companies within the life sciences sector. Lightstone Ventures primarily focuses on:
- Biotech companies: Developing new pharmaceutical drugs, therapies, and biotechnological solutions.
- Medtech companies: Creating advanced medical devices, diagnostics, and healthcare technologies.
This successful fundraise underscores Lightstone Ventures' continued commitment to advancing medical innovation and supporting high-potential ventures in the biotech and medtech industries.
Key Fund Information
| Fund Name | Capital Commitments | Closing Date | Investment Focus | Status |
|---|---|---|---|---|
| Lightstone Ventures III | $375 million | September 24, 2021 | Biotech, Medtech | Over-subscribed |
For more details on the fund's closing, you can refer to information available from Cooley LLP.
